Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2015, Article ID 193698, 8 pages
http://dx.doi.org/10.1155/2015/193698
Research Article

The Association between the PR Interval and Left Ventricular Measurements in the Multiethnic Study of Atherosclerosis

1Department of Public Health Sciences, Loyola University Chicago, Maywood, IL 60153, USA
2Department of Medicine, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
3Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA

Received 9 June 2015; Revised 23 August 2015; Accepted 9 September 2015

Academic Editor: Thomas Klingenheben

Copyright © 2015 Michael P. Husby et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Shulman, P. Aagaard, F. Kargoli et al., “Validation of PR interval length as a criterion for development of atrial fibrillation in non-Hispanic whites, African Americans and Hispanics,” Journal of Electrocardiology, vol. 48, no. 4, pp. 703–709, 2015. View at Publisher · View at Google Scholar
  2. C. Fisch, “Electrocardiography,” in Heart Disease: A Textbook of Cardiovascular Medicine, E. Braunwald, Ed., pp. 108–152, W.B. Saunders Company, Philadelphia, Pa, USA, 5th edition, 1997. View at Google Scholar
  3. D. Mymin, F. A. L. Mathewson, R. B. Tate, and J. Manfreda, “The natural history of primary first-degree atrioventricular heart block,” The New England Journal of Medicine, vol. 315, no. 19, pp. 1183–1187, 1986. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Erikssen and J. E. Otterstad, “Natural course of a prolonged PR interval and the relation between PR and incidence of coronary heart disease. A 7-year follow-up study of 1832 apparently healthy men aged 40–59 years,” Clinical Cardiology, vol. 7, no. 1, pp. 6–13, 1984. View at Publisher · View at Google Scholar · View at Scopus
  5. J. M. Packard, J. S. Graettinger, and A. Graybiel, “Analysis of the electrocardiograms obtained from 1000 young healthy aviators: ten year follow-up,” Circulation, vol. 10, no. 3, pp. 384–400, 1954. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Cheng, M. J. Keyes, M. G. Larson et al., “Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block,” Journal of the American Medical Association, vol. 301, no. 24, pp. 2571–2577, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. W. Magnani, N. Wang, K. P. Nelson et al., “Electrocardiographic PR interval and adverse outcomes in older adults: the health, aging, and body composition study,” Circulation: Arrhythmia and Electrophysiology, vol. 6, no. 1, pp. 84–90, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. R. K. Crisel, R. Farzaneh-Far, B. Na, and M. A. Whooley, “First-degree atrioventricular block is associated with heart failure and death in persons with stable coronary artery disease: data from the Heart and Soul Study,” European Heart Journal, vol. 32, no. 15, pp. 1875–1880, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Mozaffarian, E. J. Benjamin, A. S. Go et al., “Heart disease and stroke statistics—2015 update: a report from the American Heart Association,” Circulation, vol. 131, no. 4, pp. e29–e322, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. J. B. Nielsen, A. Pietersen, C. Graff et al., “Risk of atrial fibrillation as a function of the electrocardiographic PR interval: results from the Copenhagen ECG Study,” Heart Rhythm, vol. 10, no. 9, pp. 1249–1256, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Holmqvist, K. L. Thomas, S. Broderick et al., “Clinical outcome as a function of the PR-interval—there is virtue in moderation: data from the Duke Databank for cardiovascular disease,” Europace, vol. 17, no. 6, pp. 978–985, 2015. View at Publisher · View at Google Scholar
  12. R. Lieberman, L. Padeletti, J. Schreuder et al., “Ventricular pacing lead location alters systemic hemodynamics and left ventricular function in patients with and without reduced ejection fraction,” Journal of the American College of Cardiology, vol. 48, no. 8, pp. 1634–1641, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. P. P. Karpawich, R. Rabah, and J. E. Haas, “Altered cardiac histology following apical right ventricular pacing in patients with congenital atrioventricular block,” Pacing & Clinical Electrophysiology, vol. 22, no. 9, pp. 1372–1377, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Gervais, C. Leclercq, A. Shankar et al., “Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial,” European Journal of Heart Failure, vol. 11, no. 7, pp. 699–705, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Natori, S. Lai, J. P. Finn et al., “Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity,” American Journal of Roentgenology, vol. 186, no. 6, pp. S357–S365, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. D. DuBois and E. DuBois, “A formula to estimate the approximate surface area if height and weight be known,” Archives of Internal Medicine, vol. 17, pp. 863–871, 1916. View at Google Scholar
  17. M. H. Drazner, J. E. Rame, E. K. Marino et al., “Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study,” Journal of the American College of Cardiology, vol. 43, no. 12, pp. 2207–2215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. B. D. Rosen, T. Edvardsen, S. Lai et al., “Left ventricular concentric remodeling is associated with decreased global and regional systolic function: the multi-ethnic study of atherosclerosis,” Circulation, vol. 112, no. 7, pp. 984–991, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. R. B. Schnabel, T. Aspelund, G. Li et al., “Validation of an atrial fibrillation risk algorithm in Whites and African Americans,” Archives of Internal Medicine, vol. 170, no. 21, pp. 1909–1917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. R. B. Schnabel, L. M. Sullivan, D. Levy et al., “Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study,” The Lancet, vol. 373, no. 9665, pp. 739–745, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Alonso, B. P. Krijthe, T. Aspelund et al., “Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium,” Journal of the American Heart Association, vol. 2, no. 2, Article ID e000102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Z. Soliman, M. Cammarata, and Y. Li, “Explaining the inconsistent associations of PR interval with mortality: the role of P-duration contribution to the length of PR interval,” Heart Rhythm, vol. 11, no. 1, pp. 93–98, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. J. W. Magnani, E. Z. Gorodeski, V. M. Johnson et al., “P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and Nutrition Examination Survey,” Heart Rhythm, vol. 8, no. 1, pp. 93–100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Chatterjee, C. Bavishi, P. Sardar et al., “Meta-analysis of left ventricular hypertrophy and sustained arrhythmias,” The American Journal of Cardiology, vol. 114, no. 7, pp. 1049–1052, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Wachtell, M. Lehto, E. Gerdts et al., “Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention for End point reduction in hypertension (LIFE) study,” Journal of the American College of Cardiology, vol. 45, no. 5, pp. 712–719, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. P. M. Okin, K. Wachtell, R. B. Devereux et al., “Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension,” The Journal of the American Medical Association, vol. 296, no. 10, pp. 1242–1248, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Wolk, “Arrhythmogenic mechanisms in left ventricular hypertrophy,” Europace, vol. 2, no. 3, pp. 216–223, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. A. S. Go, E. M. Hylek, K. A. Phillips et al., “Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study,” The Journal of the American Medical Association, vol. 285, no. 18, pp. 2370–2375, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Berry, S. Stewart, E. M. Payne, J. D. McArthur, and J. J. V. McMurray, “Electrical cardioversion for atrial fibrillation: outcomes in ‘real-life’ clinical practice,” International Journal of Cardiology, vol. 81, no. 1, pp. 29–35, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Tremblay-Gravel, M. White, D. Roy et al., “Blood pressure and atrial fibrillation: a combined AF-CHF and AFFIRM analysis,” Journal of Cardiovascular Electrophysiology, vol. 26, no. 5, pp. 509–514, 2015. View at Publisher · View at Google Scholar
  31. J. W. Magnani, F. L. Lopez, E. Z. Soliman, R. F. Maclehose, R. S. Crow, and A. Alonso, “P wave indices, obesity, and the metabolic syndrome: the atherosclerosis risk in communities study,” Obesity, vol. 20, no. 3, pp. 666–672, 2012. View at Publisher · View at Google Scholar · View at Scopus